Association between early treatment with Qingfei Paidu decoction and favorable clinical outcomes in patients with COVID-19: A retrospective multicenter cohort study
Top Cited Papers
Open Access
- 9 November 2020
- journal article
- research article
- Published by Elsevier BV in Pharmacological Research
- Vol. 161, 105290
- https://doi.org/10.1016/j.phrs.2020.105290
Abstract
No abstract availableFunding Information
- National Science and Technology Major Project (2018ZX10101001-005-003, 2018ZX10101001-005-004)
This publication has 19 references indexed in Scilit:
- Core Outcome Set for Clinical Trials on Coronavirus Disease 2019 (COS-COVID)Engineering, 2020
- Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, ChinaJAMA Internal Medicine, 2020
- Clinical and epidemiological characteristics of 1420 European patients with mild‐to‐moderate coronavirus disease 2019Journal of Internal Medicine, 2020
- Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, ChinaJAMA Neurology, 2020
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19The New England Journal of Medicine, 2020
- Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trialThe Lancet, 2020
- Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington StateJAMA, 2020
- Short-term outcomes of COVID-19 and risk factors for progressionEuropean Respiratory Journal, 2020
- Clinical features of the first cases and a cluster of Coronavirus Disease 2019 (COVID-19) in Bolivia imported from Italy and SpainTravel Medicine and Infectious Disease, 2020
- Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 7)Chinese Medical Journal, 2020